Search

A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukemia

Patients with chronic lymphocytic leukemia (CLL) that has recurred or isn’t responding to standard treatment need new therapies. A new combination of two targeted therapies is showing potential to eliminate CLL in these circumstances.

Read more

How to apply

The CRTH 2025 call for applications is now closed. Timelines
Application CRTH 2025
Deadline: September 24, 2024 (15:00 CEST)

Notification
November 2024

Questions: training@ehaweb. orgDownload the Signature letter template.

Read more

Infections in Hematology Webinar Series

Monthly webinars to provide theoretical and practical knowledge for hematologists whose patients develop infection complications. What is the Infections in Hematology Webinar Series?The series is an EHA SWG on Infections in Hematology initiative.

Read more

ESID-EHA-SIOPE Focused Symposium 2025

Explore the interplay of immunodeficiency, hematologic conditions, and pediatric cancer at a unique, collaborative symposium. Dates: November 18–20, 2025
Location: Vienna, Austria

Abstract submission is open until 23:59 (CEST) on June 10, 2025.

Read more

HARMONY: Innovative Medicines Initiative approves € 40 million project for better care of patients with hematologic malignancies

HARMONY will capture, integrate, analyze and harmonize anonymous patient data from high-quality multidisciplinary sources to unlock valuable knowledge on multiple myeloma (MM), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), non-Hodgkins lymphoma (NHL), myelodysplastic syndromes (MDS)…

Read more